Results 241 to 250 of about 749,373 (347)
Prognostic analysis of very early onset pancreatic cancer: a population-based analysis
Dongjun Dai +4 more
openalex +1 more source
Multiscale Construction, Evaluation, and Application of Organoids
Organoids are pivotal models with transformative biomedical potential. A comprehensive multi‐scale perspective is presented, encompassing dual‐scale construction, four‐dimensional evaluation, triple‐point application, and an analysis of the current challenges faced by organoid technology, aiming to advance organoid research and its biomedical ...
Wanting Ma +5 more
wiley +1 more source
Chemotherapy Regimens and Survival in Pancreatic Cancer-A Ten-Year Single Centre Overview. [PDF]
Tranvik H +3 more
europepmc +1 more source
The fused EV platform AS16‐EL@MPLA/p‐FX reprograms tumor cells into cytokine‐producing factories that continuously secrete XCL1 and FLT3L to recruit and differentiate cDC1s, while embedded MPLA activates them through TLR4 signaling and AS16 prevents their exhaustion, thereby enhancing antitumor immunity and establishing durable immune memory against ...
Shuiling Jin +16 more
wiley +1 more source
Mitochondrial superoxide dismutase controls metabolic plasticity in pancreatic cancer. [PDF]
Ramasubramanian S +5 more
europepmc +1 more source
A biomimetic self‐assembly strategy, Procyanidin Capsules (PC‐Ca), has been developed, which has great stability, bioavailability, and liver‐targeting efficacy and modulates the KEAP1‐NRF2 axis to inhibit ROS formation and necroptosis, regulate mitochondrial homeostasis through the PGAM5/DRP1/PINK1 signaling pathway in thioacetamide (TAA)‐induced ALF ...
Qing Shi +8 more
wiley +1 more source
Surgery based on resectability status of pancreatic cancer: a narrative review. [PDF]
Einama T +10 more
europepmc +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source
B2M regulates ELANE in pyroptosis to affect pancreatic cancer progression. [PDF]
Xie H, Hu X, Cai Y, Zhu S, Deng Z.
europepmc +1 more source

